The last two decades have seen an expansion of research into novel pathogens. Along with researchers looking for new diseases in the wild, thousands of biocontainment labs around the world now handle potentially deadly viruses and bacteria. But the emergence of COVID-19—and the possibility that it may have escaped from a lab—is leading to a rethinking of the entire field, report David Willman and Joby Warrick in the Washington Post. |
